Change of skeletal muscle mass in patients with pheochromocytoma
The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance an...
Saved in:
| Published in | Journal of bone and mineral metabolism Vol. 37; no. 4; pp. 694 - 702 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Tokyo
Springer Japan
01.07.2019
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0914-8779 1435-5604 1435-5604 |
| DOI | 10.1007/s00774-018-0959-3 |
Cover
| Abstract | The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM (
β
= − 0.171,
P
= 0.006) and UNM (
β
= − 0.249,
P
< 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% (
P
= 0.022) and SMI by 6.6% (
P
= 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65–40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism. |
|---|---|
| AbstractList | The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM (β = − 0.171, P = 0.006) and UNM (β = − 0.249, P < 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% (P = 0.022) and SMI by 6.6% (P = 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65–40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism. The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM ( β = − 0.171, P = 0.006) and UNM ( β = − 0.249, P < 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% ( P = 0.022) and SMI by 6.6% ( P = 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65–40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism. The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM (β = - 0.171, P = 0.006) and UNM (β = - 0.249, P < 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% (P = 0.022) and SMI by 6.6% (P = 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65-40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism. The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM (β = - 0.171, P = 0.006) and UNM (β = - 0.249, P < 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% (P = 0.022) and SMI by 6.6% (P = 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65-40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism.The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects of catecholamine metabolites on body composition in subjects with pheochromocytoma. After body compositions using bioelectrical impedance analysis, urinary metanephrine (UM), and urinary normetanephrine (UNM) were measured in 16 patients with pheochromocytoma and 224 patients with nonfunctioning adrenal incidentaloma (NFAI), we compared skeletal muscle mass and fat mass (FM) between the two groups. After adjustments for confounders, UM (β = - 0.171, P = 0.006) and UNM (β = - 0.249, P < 0.001) levels were correlated inversely with skeletal muscle mass index (SMI), but not FM or percentage FM (pFM), in all subjects. Patients with pheochromocytoma had lower ASM by 7.7% (P = 0.022) and SMI by 6.6% (P = 0.001) than patients with NFAI. Conversely, FM and pFM were not statistically different between the two groups. The odds ratio for low skeletal muscle mass in the presence of pheochromocytoma was 10.33 (95% confidence interval, 2.65-40.22). Our results indicate that patients with pheochromocytoma have a reduced skeletal muscle mass and suggest that catecholamine excess has adverse effects on skeletal muscle metabolism. |
| Author | Lee, Seung Hun Ahn, Seong Hee Kim, Hyeonmok Cho, Yoon Young Koh, Jung-Min Kwak, Mi Kyung Kim, Beom-Jun Suh, Sunghwan Song, Kee-Ho Kim, Jae Hyeon |
| Author_xml | – sequence: 1 givenname: Seung Hun surname: Lee fullname: Lee, Seung Hun organization: Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine – sequence: 2 givenname: Mi Kyung surname: Kwak fullname: Kwak, Mi Kyung organization: Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine – sequence: 3 givenname: Seong Hee surname: Ahn fullname: Ahn, Seong Hee organization: Division of Endocrinology and Metabolism, Department of Medicine, Inha University Hospital, Inha University School of Medicine – sequence: 4 givenname: Hyeonmok surname: Kim fullname: Kim, Hyeonmok organization: Department of Medicine, Seoul Medical Center – sequence: 5 givenname: Yoon Young surname: Cho fullname: Cho, Yoon Young organization: Division of Endocrinology and Metabolism, Department of Medicine, Gyeongsang National University School of Medicine – sequence: 6 givenname: Sunghwan surname: Suh fullname: Suh, Sunghwan organization: Division of Endocrinology and Metabolism, Department of Medicine, Dong-A University Medical Center, Dong-A, University College of Medicine – sequence: 7 givenname: Kee-Ho surname: Song fullname: Song, Kee-Ho organization: Division of Endocrinology and Metabolism, Department of Medicine, Konkuk University Medical Center, Konkuk University School of Medicine – sequence: 8 givenname: Jung-Min surname: Koh fullname: Koh, Jung-Min organization: Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine – sequence: 9 givenname: Jae Hyeon surname: Kim fullname: Kim, Jae Hyeon email: jaehyeon@skku.edu organization: Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine – sequence: 10 givenname: Beom-Jun surname: Kim fullname: Kim, Beom-Jun email: umkbj0825@amc.seoul.kr organization: Division of Endocrinology and Metabolism, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30238430$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1P3DAQhi1EBQvlB3BBkbhwCZ1Z2-v1rWjFl4TUS3u2HHvChibxYjtC_Pt6tUAlpNaH8eV5Z0bPHLH9MYzE2CnCJQKob6kUJWrAZQ1a6prvsRkKLmu5ALHPZqBR1Eul9CE7SukJAJVUeMAOOcz5UnCYse-rtR0fqQptlX5TT9n21TAl11M12JSqbqw2Nnc05lS9dHldbdYU3DqGIbjXHAb7lX1pbZ_o5O0_Zr9urn-u7uqHH7f3q6uH2nG9yLVqrAdy0je-QQGWgyLyUjsEooWWTWvnDkkLZ71XHGzrZOOd9tJb5Aj8mF3s-m5ieJ4oZTN0yVHf25HClMwcyxNcKF7Q80_oU5jiWLbbUoCoOC4LdfZGTc1A3mxiN9j4at7dFAB3gIshpUjtB4Jgtv7Nzr8p_s3Wv9mOVp8yrsvFXxhztF3_3-R8l0xlSrlI_Lv0v0N_AMoGmSY |
| CitedBy_id | crossref_primary_10_31083_j_rcm2309296 crossref_primary_10_3389_fendo_2024_1370525 crossref_primary_10_1002_jcsm_13071 crossref_primary_10_1016_j_beem_2024_101956 crossref_primary_10_1113_JP281819 crossref_primary_10_1210_clinem_dgab401 crossref_primary_10_1080_07435800_2021_1954942 crossref_primary_10_3390_cancers14081967 crossref_primary_10_1007_s12020_021_02858_z crossref_primary_10_1007_s12028_023_01751_z crossref_primary_10_1210_clinem_dgaa954 crossref_primary_10_1210_jcemcr_luad037 |
| Cites_doi | 10.1016/j.metabol.2015.03.004 10.1093/ageing/aft063 10.3109/10641969509037423 10.1152/physrev.00028.2007 10.1152/japplphysiol.00873.2006 10.1161/01.RES.62.1.37 10.1097/JES.0b013e3181f44f11 10.2527/1992.701115x 10.1152/ajpendo.00560.2003 10.1093/gerona/gls071 10.1016/j.jamda.2013.11.025 10.1016/0006-291X(86)90442-0 10.1152/jappl.2000.89.2.465 10.1530/EJE-16-0467 10.1210/jc.2012-3625 10.1016/0742-8413(89)90215-6 10.1210/jc.2003-030000 10.1016/0006-2952(91)90516-8 10.1016/j.pharmthera.2006.11.004 10.1007/s40618-014-0106-5 10.1210/jc.2014-1498 10.1530/EJE-17-0372 10.1016/j.jamda.2016.05.016 10.1152/japplphysiol.91067.2008 10.1113/jphysiol.2014.278358 10.1152/japplphysiol.01081.2003 10.1097/00004872-200309000-00020 10.1055/s-0042-124189 10.1002/mus.10092 10.1007/s12020-016-1049-8 10.1111/cen.13145 10.1152/ajpendo.2000.279.3.E663 10.1007/s00592-009-0112-9 10.1038/nrendo.2012.49 |
| ContentType | Journal Article |
| Copyright | The Japanese Society for Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2018 Journal of Bone and Mineral Metabolism is a copyright of Springer, (2018). All Rights Reserved. |
| Copyright_xml | – notice: The Japanese Society for Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2018 – notice: Journal of Bone and Mineral Metabolism is a copyright of Springer, (2018). All Rights Reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00774-018-0959-3 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1435-5604 |
| EndPage | 702 |
| ExternalDocumentID | 30238430 10_1007_s00774_018_0959_3 |
| Genre | Randomized Controlled Trial Multicenter Study Journal Article |
| GrantInformation_xml | – fundername: Korean government, MSIP grantid: 2016M3A9E8941329 – fundername: Dong-A ST grantid: 2011-04-090 – fundername: Asan Institute for Life Sciences, Asan Medical Center grantid: 2018-568 funderid: http://dx.doi.org/10.13039/501100005006 – fundername: Asan Institute for Life Sciences, Asan Medical Center grantid: 2018-568 |
| GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSNA ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI CCPQU CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- NAPCQ NB0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 QOK QOR QOS R89 R9I RHV RNS ROL RPX RRX RSV S16 S27 S37 S3B SAP SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX VC2 W23 W48 WJK WK8 WOW YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX ~KM -Y2 1SB 2.D 28- 2P1 2VQ 3O- 5QI AANXM AAPKM AARHV AAYTO AAYXX ABBRH ABDBE ABFSG ABQSL ABULA ACBXY ACMFV ACSTC ACUDM ADHKG AEBTG AEFIE AEKMD AEZWR AFDZB AFEXP AFHIU AFOHR AGGDS AGQPQ AHPBZ AHWEU AIXLP AJBLW ATHPR BBWZM CAG CITATION COF EN4 GRRUI H13 KOW N2Q NDZJH O9- OVD PHGZM PHGZT R4E RIG RNI RZK S1Z S26 S28 SCLPG SDE T16 TEORI UZXMN VFIZW CGR CUY CVF ECM EIF NPM 7QP 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c396t-7bad0ec5dbdb140a307eed59c10ee695bfa2c1e94cadd730afc5bdc9d5da13103 |
| IEDL.DBID | BENPR |
| ISSN | 0914-8779 1435-5604 |
| IngestDate | Fri Sep 05 11:36:17 EDT 2025 Fri Jul 25 04:40:01 EDT 2025 Wed Feb 19 02:27:34 EST 2025 Thu Apr 24 23:07:09 EDT 2025 Tue Jul 01 04:35:23 EDT 2025 Fri Feb 21 02:37:37 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Sarcopenia Pheochromocytoma Catecholamine Skeletal muscle |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c396t-7bad0ec5dbdb140a307eed59c10ee695bfa2c1e94cadd730afc5bdc9d5da13103 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| PMID | 30238430 |
| PQID | 2110117318 |
| PQPubID | 1456336 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2111143473 proquest_journals_2110117318 pubmed_primary_30238430 crossref_primary_10_1007_s00774_018_0959_3 crossref_citationtrail_10_1007_s00774_018_0959_3 springer_journals_10_1007_s00774_018_0959_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-07-01 |
| PublicationDateYYYYMMDD | 2019-07-01 |
| PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Tokyo |
| PublicationPlace_xml | – name: Tokyo – name: Japan |
| PublicationTitle | Journal of bone and mineral metabolism |
| PublicationTitleAbbrev | J Bone Miner Metab |
| PublicationTitleAlternate | J Bone Miner Metab |
| PublicationYear | 2019 |
| Publisher | Springer Japan Springer Nature B.V |
| Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
| References | LeeSHSongKHKimJParkSAhnSHKimHChoYYSuhSKimBJKimJHKohJMNew diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the co-work of adrenal research studyClin Endocrinol201786101810.1111/cen.131451:CAS:528:DC%2BC28XitFeitL7K(Oxf) ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the asian working group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.02524461239 ChoYYSongKHKimYNAhnSHKimHParkSSuhSKimBJLeeSYChunSKohJMLeeSHKimJHSymptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offsEndocrine20165420621610.1007/s12020-016-1049-81:CAS:528:DC%2BC28Xht1KrtL%2FF27481364 NavegantesLCResanoNMMiglioriniRHKettelhutICRole of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscleAm J Physiol Endocrinol Metab2000279E663E66810.1152/ajpendo.2000.279.3.E6631:STN:280:DC%2BD3cvjsFensQ%3D%3D10950836 KlineWOPanaroFJYangHBodineSCRapamycin inhibits the growth and muscle-sparing effects of clenbuterolJ Appl Physiol (1985)200710274074710.1152/japplphysiol.00873.20061:CAS:528:DC%2BD2sXjtFyrsb8%3D JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol20008946547110.1152/jappl.2000.89.2.4651:STN:280:DC%2BD3cvjslShsw%3D%3D10926627 BeitzelFGregorevicPRyallJGPlantDRSillenceMNLynchGSBeta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injuryJ Appl Physiol2004961385139210.1152/japplphysiol.01081.20031:CAS:528:DC%2BD2cXjtlGiu7g%3D14607853 WiesnerTDBluherMWindgassenMPaschkeRImprovement of insulin sensitivity after adrenalectomy in patients with pheochromocytomaJ Clin Endocrinol Metab2003883632363610.1210/jc.2003-0300001:CAS:528:DC%2BD3sXmsFOktrs%3D12915647 KimYSSainzRDSummersRJMolenaarPCimaterol reduces beta-adrenergic receptor density in rat skeletal musclesJ Anim Sci19927011512210.2527/1992.701115x1:CAS:528:DyaK38XhsFSmurs%3D1374751 KimYSSainzRDMolenaarPSummersRJCharacterization of beta 1- and beta 2-adrenoceptors in rat skeletal musclesBiochem Pharmacol1991421783178910.1016/0006-2952(91)90516-81:CAS:528:DyaK3MXmslWgsL8%3D1681810 CasesABonoMGayaJJimenezWCallsJEsforzadoNRiveraFRevertLReversible decrease of surface beta 2-adrenoceptor number and response in lymphocytes of patients with pheochromocytomaClin Exp Hypertens19951753754910.3109/106419695090374231:STN:280:DyaK2MzjvVWqsw%3D%3D7613527 PetrakOHaluzikovaDKavalkovaPStrauchBRosaJHolajRBrabcova VrankovaAMichalskyDHaluzikMZelinkaTWidimskyJJrChanges in energy metabolism in pheochromocytomaJ Clin Endocrinol Metab2013981651165810.1210/jc.2012-36251:CAS:528:DC%2BC3sXmtFehtL0%3D23436923 KimYSLeeYChungYSLeeDJJooNSHongDSongGKimHJChoiYJKimKMPrevalence of sarcopenia and sarcopenic obesity in the korean population based on the fourth korean national health and nutritional examination surveysJ Gerontol A Biol Sci Med Sci2012671107111310.1093/gerona/gls07122431554 LynchGSRyallJGRole of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and diseasePhysiol Rev20088872976710.1152/physrev.00028.20071:CAS:528:DC%2BD1cXls1KhsLs%3D18391178 HinkleRTHodgeKMCodyDBSheldonRJKobilkaBKIsfortRJSkeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptorMuscle Nerve20022572973410.1002/mus.100921:CAS:528:DC%2BD38Xkt12qs74%3D11994968 OkamuraTNakajimaYSatohTHashimotoKSapkotaSYamadaEOkadaSFukudaJHiguchiTTsushimaYYamadaMChanges in visceral and subcutaneous fat mass in patients with pheochromocytomaMetabolism20156470671210.1016/j.metabol.2015.03.0041:CAS:528:DC%2BC2MXlsVOjur8%3D25819736 FassnachtMArltWBancosIDralleHNewell-PriceJSahdevATabarinATerzoloMTsagarakisSDekkersOMManagement of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the european network for the study of adrenal tumorsEur J Endocrinol2016175G1G3410.1530/EJE-16-04671:CAS:528:DC%2BC2sXhtFyms7bP27390021 RichardsJCLuckasenGJLarsonDGDinennoFARole of alpha-adrenergic vasoconstriction in regulating skeletal muscle blood flow and vascular conductance during forearm exercise in ageing humansJ Physiol20145924775478810.1113/jphysiol.2014.2783581:CAS:528:DC%2BC2cXhvVCgtrvL251940404253476 ChenLKLeeWJPengLNLiuLKAraiHAkishitaMRecent advances in Sarcopenia research in Asia: 2016 update from the Asian Working Group for SarcopeniaJ Am Med Dir Assoc201617e761e76710.1016/j.jamda.2016.05.016 SpyroglouAAdolfCHahnerSQuinklerMLadurnerRReinckeMBeuschleinFChanges in body mass index in pheochromocytoma patients following adrenalectomyHorm Metab Res20174920821310.1055/s-0042-1241891:CAS:528:DC%2BC2sXjt1aitbg%3D28222463 La Batide-AlanoreAChatellierGPlouinPFDiabetes as a marker of pheochromocytoma in hypertensive patientsJ Hypertens2003211703170710.1097/00004872-200309000-0002012923403 FaberJEIn situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculationCirc Res198862375010.1161/01.RES.62.1.371:CAS:528:DyaL1cXmvFGmtQ%3D%3D2891454 FrostRANystromGJLangCHEpinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activityAm J Physiol Endocrinol Metab2004286E809E81710.1152/ajpendo.00560.20031:CAS:528:DC%2BD2cXkt1emurc%3D14722032 BacurauAVJardimMAFerreiraJCBecharaLRBuenoCRJrAlba-LoureiroTCNegraoCECasariniDECuriRRamiresPRMoriscotASBrumPCSympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise trainingJ Appl Physiol20091061631164010.1152/japplphysiol.91067.200819179649 HongARKimJHParkKSKimKYLeeJHKongSHLeeSYShinCSKimSWKimSYOptimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practiceEur J Endocrinol201717747548310.1530/EJE-17-03721:CAS:528:DC%2BC1cXhvFagtbrK HeWGoodkindDKowalPAn Aging World: 20152016WashingtonUS Census Bureau ResminiEMinutoFColaoAFeroneDSecondary diabetes associated with principal endocrinopathies: the impact of new treatment modalitiesActa Diabetol200946859510.1007/s00592-009-0112-91:CAS:528:DC%2BD1MXlsFKks78%3D19322513 LendersJWDuhQYEisenhoferGGimenez-RoqueploAPGrebeSKMuradMHNaruseMPacakKYoungWFJrPheochromocytoma and paraganglioma: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab2014991915194210.1210/jc.2014-14981:CAS:528:DC%2BC2cXps12rtr8%3D24893135 RyuMJoJLeeYChungYSKimKMBaekWCAssociation of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the fourth Korea national health and nutrition examination surveyAge Ageing20134273474010.1093/ageing/aft06323761456 LynchGSSchertzerJDRyallJGTherapeutic approaches for muscle wasting disordersPharmacol Ther200711346148710.1016/j.pharmthera.2006.11.0041:CAS:528:DC%2BD2sXislKjsLs%3D17258813 McElligottMABarretoAJrChaungLYEffect of continuous and intermittent clenbuterol feeding on rat growth rate and muscleComp Biochem Physiol C19899213513810.1016/0742-8413(89)90215-61:STN:280:DyaL1M3ltVCksg%3D%3D2566434 RattiganSApplebyGJEdwardsSJMcKinstryWJColquhounEQClarkMGRichterEAAlpha-adrenergic receptors in rat skeletal muscleBiochem Biophys Res Commun19861361071107710.1016/0006-291X(86)90442-01:CAS:528:DyaL28XktVWhsLk%3D3013164 CarsonJABaltgalvisKAInterleukin 6 as a key regulator of muscle mass during cachexiaExerc Sport Sci Rev20103816817610.1097/JES.0b013e3181f44f1130653003065300 PedersenBKFebbraioMAMuscles, exercise and obesity: skeletal muscle as a secretory organNat Rev Endocrinol2012845746510.1038/nrendo.2012.491:CAS:528:DC%2BC38XhtVOmtLrJ TunaMMImgaNNDoganBAYilmazFMTopcuogluCAkbabaGBerkerDGulerSNon-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosisJ Endocrinol Invest20143776576810.1007/s40618-014-0106-51:CAS:528:DC%2BC28XhvV2qtL0%3D24923898 AR Hong (959_CR33) 2017; 177 T Okamura (959_CR6) 2015; 64 MA McElligott (959_CR16) 1989; 92 SH Lee (959_CR25) 2017; 86 MM Tuna (959_CR28) 2014; 37 LC Navegantes (959_CR10) 2000; 279 GS Lynch (959_CR12) 2007; 113 AV Bacurau (959_CR17) 2009; 106 F Beitzel (959_CR13) 2004; 96 I Janssen (959_CR35) 2000; 89 WO Kline (959_CR11) 2007; 102 RT Hinkle (959_CR14) 2002; 25 LK Chen (959_CR5) 2016; 17 M Fassnacht (959_CR32) 2016; 175 JE Faber (959_CR18) 1988; 62 E Resmini (959_CR22) 2009; 46 M Ryu (959_CR4) 2013; 42 TD Wiesner (959_CR23) 2003; 88 RA Frost (959_CR31) 2004; 286 YS Kim (959_CR8) 1991; 42 YS Kim (959_CR15) 1992; 70 GS Lynch (959_CR9) 2008; 88 JA Carson (959_CR29) 2010; 38 A Batide-Alanore La (959_CR21) 2003; 21 YS Kim (959_CR3) 2012; 67 JW Lenders (959_CR20) 2014; 99 JC Richards (959_CR27) 2014; 592 A Spyroglou (959_CR24) 2017; 49 BK Pedersen (959_CR30) 2012; 8 YY Cho (959_CR26) 2016; 54 O Petrak (959_CR7) 2013; 98 A Cases (959_CR34) 1995; 17 LK Chen (959_CR2) 2014; 15 W He (959_CR1) 2016 S Rattigan (959_CR19) 1986; 136 |
| References_xml | – reference: HeWGoodkindDKowalPAn Aging World: 20152016WashingtonUS Census Bureau – reference: FassnachtMArltWBancosIDralleHNewell-PriceJSahdevATabarinATerzoloMTsagarakisSDekkersOMManagement of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the european network for the study of adrenal tumorsEur J Endocrinol2016175G1G3410.1530/EJE-16-04671:CAS:528:DC%2BC2sXhtFyms7bP27390021 – reference: ResminiEMinutoFColaoAFeroneDSecondary diabetes associated with principal endocrinopathies: the impact of new treatment modalitiesActa Diabetol200946859510.1007/s00592-009-0112-91:CAS:528:DC%2BD1MXlsFKks78%3D19322513 – reference: KimYSLeeYChungYSLeeDJJooNSHongDSongGKimHJChoiYJKimKMPrevalence of sarcopenia and sarcopenic obesity in the korean population based on the fourth korean national health and nutritional examination surveysJ Gerontol A Biol Sci Med Sci2012671107111310.1093/gerona/gls07122431554 – reference: La Batide-AlanoreAChatellierGPlouinPFDiabetes as a marker of pheochromocytoma in hypertensive patientsJ Hypertens2003211703170710.1097/00004872-200309000-0002012923403 – reference: RattiganSApplebyGJEdwardsSJMcKinstryWJColquhounEQClarkMGRichterEAAlpha-adrenergic receptors in rat skeletal muscleBiochem Biophys Res Commun19861361071107710.1016/0006-291X(86)90442-01:CAS:528:DyaL28XktVWhsLk%3D3013164 – reference: TunaMMImgaNNDoganBAYilmazFMTopcuogluCAkbabaGBerkerDGulerSNon-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosisJ Endocrinol Invest20143776576810.1007/s40618-014-0106-51:CAS:528:DC%2BC28XhvV2qtL0%3D24923898 – reference: ChenLKLeeWJPengLNLiuLKAraiHAkishitaMRecent advances in Sarcopenia research in Asia: 2016 update from the Asian Working Group for SarcopeniaJ Am Med Dir Assoc201617e761e76710.1016/j.jamda.2016.05.016 – reference: CarsonJABaltgalvisKAInterleukin 6 as a key regulator of muscle mass during cachexiaExerc Sport Sci Rev20103816817610.1097/JES.0b013e3181f44f1130653003065300 – reference: RyuMJoJLeeYChungYSKimKMBaekWCAssociation of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the fourth Korea national health and nutrition examination surveyAge Ageing20134273474010.1093/ageing/aft06323761456 – reference: WiesnerTDBluherMWindgassenMPaschkeRImprovement of insulin sensitivity after adrenalectomy in patients with pheochromocytomaJ Clin Endocrinol Metab2003883632363610.1210/jc.2003-0300001:CAS:528:DC%2BD3sXmsFOktrs%3D12915647 – reference: KimYSSainzRDMolenaarPSummersRJCharacterization of beta 1- and beta 2-adrenoceptors in rat skeletal musclesBiochem Pharmacol1991421783178910.1016/0006-2952(91)90516-81:CAS:528:DyaK3MXmslWgsL8%3D1681810 – reference: HinkleRTHodgeKMCodyDBSheldonRJKobilkaBKIsfortRJSkeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptorMuscle Nerve20022572973410.1002/mus.100921:CAS:528:DC%2BD38Xkt12qs74%3D11994968 – reference: ChoYYSongKHKimYNAhnSHKimHParkSSuhSKimBJLeeSYChunSKohJMLeeSHKimJHSymptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offsEndocrine20165420621610.1007/s12020-016-1049-81:CAS:528:DC%2BC28Xht1KrtL%2FF27481364 – reference: BacurauAVJardimMAFerreiraJCBecharaLRBuenoCRJrAlba-LoureiroTCNegraoCECasariniDECuriRRamiresPRMoriscotASBrumPCSympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise trainingJ Appl Physiol20091061631164010.1152/japplphysiol.91067.200819179649 – reference: LeeSHSongKHKimJParkSAhnSHKimHChoYYSuhSKimBJKimJHKohJMNew diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the co-work of adrenal research studyClin Endocrinol201786101810.1111/cen.131451:CAS:528:DC%2BC28XitFeitL7K(Oxf) – reference: ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the asian working group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.02524461239 – reference: FaberJEIn situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculationCirc Res198862375010.1161/01.RES.62.1.371:CAS:528:DyaL1cXmvFGmtQ%3D%3D2891454 – reference: SpyroglouAAdolfCHahnerSQuinklerMLadurnerRReinckeMBeuschleinFChanges in body mass index in pheochromocytoma patients following adrenalectomyHorm Metab Res20174920821310.1055/s-0042-1241891:CAS:528:DC%2BC2sXjt1aitbg%3D28222463 – reference: BeitzelFGregorevicPRyallJGPlantDRSillenceMNLynchGSBeta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injuryJ Appl Physiol2004961385139210.1152/japplphysiol.01081.20031:CAS:528:DC%2BD2cXjtlGiu7g%3D14607853 – reference: KimYSSainzRDSummersRJMolenaarPCimaterol reduces beta-adrenergic receptor density in rat skeletal musclesJ Anim Sci19927011512210.2527/1992.701115x1:CAS:528:DyaK38XhsFSmurs%3D1374751 – reference: PetrakOHaluzikovaDKavalkovaPStrauchBRosaJHolajRBrabcova VrankovaAMichalskyDHaluzikMZelinkaTWidimskyJJrChanges in energy metabolism in pheochromocytomaJ Clin Endocrinol Metab2013981651165810.1210/jc.2012-36251:CAS:528:DC%2BC3sXmtFehtL0%3D23436923 – reference: FrostRANystromGJLangCHEpinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activityAm J Physiol Endocrinol Metab2004286E809E81710.1152/ajpendo.00560.20031:CAS:528:DC%2BD2cXkt1emurc%3D14722032 – reference: RichardsJCLuckasenGJLarsonDGDinennoFARole of alpha-adrenergic vasoconstriction in regulating skeletal muscle blood flow and vascular conductance during forearm exercise in ageing humansJ Physiol20145924775478810.1113/jphysiol.2014.2783581:CAS:528:DC%2BC2cXhvVCgtrvL251940404253476 – reference: NavegantesLCResanoNMMiglioriniRHKettelhutICRole of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscleAm J Physiol Endocrinol Metab2000279E663E66810.1152/ajpendo.2000.279.3.E6631:STN:280:DC%2BD3cvjsFensQ%3D%3D10950836 – reference: LynchGSRyallJGRole of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and diseasePhysiol Rev20088872976710.1152/physrev.00028.20071:CAS:528:DC%2BD1cXls1KhsLs%3D18391178 – reference: LendersJWDuhQYEisenhoferGGimenez-RoqueploAPGrebeSKMuradMHNaruseMPacakKYoungWFJrPheochromocytoma and paraganglioma: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab2014991915194210.1210/jc.2014-14981:CAS:528:DC%2BC2cXps12rtr8%3D24893135 – reference: PedersenBKFebbraioMAMuscles, exercise and obesity: skeletal muscle as a secretory organNat Rev Endocrinol2012845746510.1038/nrendo.2012.491:CAS:528:DC%2BC38XhtVOmtLrJ – reference: CasesABonoMGayaJJimenezWCallsJEsforzadoNRiveraFRevertLReversible decrease of surface beta 2-adrenoceptor number and response in lymphocytes of patients with pheochromocytomaClin Exp Hypertens19951753754910.3109/106419695090374231:STN:280:DyaK2MzjvVWqsw%3D%3D7613527 – reference: HongARKimJHParkKSKimKYLeeJHKongSHLeeSYShinCSKimSWKimSYOptimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practiceEur J Endocrinol201717747548310.1530/EJE-17-03721:CAS:528:DC%2BC1cXhvFagtbrK – reference: JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol20008946547110.1152/jappl.2000.89.2.4651:STN:280:DC%2BD3cvjslShsw%3D%3D10926627 – reference: OkamuraTNakajimaYSatohTHashimotoKSapkotaSYamadaEOkadaSFukudaJHiguchiTTsushimaYYamadaMChanges in visceral and subcutaneous fat mass in patients with pheochromocytomaMetabolism20156470671210.1016/j.metabol.2015.03.0041:CAS:528:DC%2BC2MXlsVOjur8%3D25819736 – reference: LynchGSSchertzerJDRyallJGTherapeutic approaches for muscle wasting disordersPharmacol Ther200711346148710.1016/j.pharmthera.2006.11.0041:CAS:528:DC%2BD2sXislKjsLs%3D17258813 – reference: McElligottMABarretoAJrChaungLYEffect of continuous and intermittent clenbuterol feeding on rat growth rate and muscleComp Biochem Physiol C19899213513810.1016/0742-8413(89)90215-61:STN:280:DyaL1M3ltVCksg%3D%3D2566434 – reference: KlineWOPanaroFJYangHBodineSCRapamycin inhibits the growth and muscle-sparing effects of clenbuterolJ Appl Physiol (1985)200710274074710.1152/japplphysiol.00873.20061:CAS:528:DC%2BD2sXjtFyrsb8%3D – volume: 64 start-page: 706 year: 2015 ident: 959_CR6 publication-title: Metabolism doi: 10.1016/j.metabol.2015.03.004 – volume: 42 start-page: 734 year: 2013 ident: 959_CR4 publication-title: Age Ageing doi: 10.1093/ageing/aft063 – volume: 17 start-page: 537 year: 1995 ident: 959_CR34 publication-title: Clin Exp Hypertens doi: 10.3109/10641969509037423 – volume: 88 start-page: 729 year: 2008 ident: 959_CR9 publication-title: Physiol Rev doi: 10.1152/physrev.00028.2007 – volume: 102 start-page: 740 year: 2007 ident: 959_CR11 publication-title: J Appl Physiol (1985) doi: 10.1152/japplphysiol.00873.2006 – volume: 62 start-page: 37 year: 1988 ident: 959_CR18 publication-title: Circ Res doi: 10.1161/01.RES.62.1.37 – volume: 38 start-page: 168 year: 2010 ident: 959_CR29 publication-title: Exerc Sport Sci Rev doi: 10.1097/JES.0b013e3181f44f11 – volume: 70 start-page: 115 year: 1992 ident: 959_CR15 publication-title: J Anim Sci doi: 10.2527/1992.701115x – volume: 286 start-page: E809 year: 2004 ident: 959_CR31 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00560.2003 – volume: 67 start-page: 1107 year: 2012 ident: 959_CR3 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/gls071 – volume: 15 start-page: 95 year: 2014 ident: 959_CR2 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2013.11.025 – volume: 136 start-page: 1071 year: 1986 ident: 959_CR19 publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(86)90442-0 – volume: 89 start-page: 465 year: 2000 ident: 959_CR35 publication-title: J Appl Physiol doi: 10.1152/jappl.2000.89.2.465 – volume: 175 start-page: G1 year: 2016 ident: 959_CR32 publication-title: Eur J Endocrinol doi: 10.1530/EJE-16-0467 – volume: 98 start-page: 1651 year: 2013 ident: 959_CR7 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3625 – volume: 92 start-page: 135 year: 1989 ident: 959_CR16 publication-title: Comp Biochem Physiol C doi: 10.1016/0742-8413(89)90215-6 – volume: 88 start-page: 3632 year: 2003 ident: 959_CR23 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-030000 – volume: 42 start-page: 1783 year: 1991 ident: 959_CR8 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(91)90516-8 – volume: 113 start-page: 461 year: 2007 ident: 959_CR12 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2006.11.004 – volume: 37 start-page: 765 year: 2014 ident: 959_CR28 publication-title: J Endocrinol Invest doi: 10.1007/s40618-014-0106-5 – volume: 99 start-page: 1915 year: 2014 ident: 959_CR20 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-1498 – volume: 177 start-page: 475 year: 2017 ident: 959_CR33 publication-title: Eur J Endocrinol doi: 10.1530/EJE-17-0372 – volume: 17 start-page: e761 year: 2016 ident: 959_CR5 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2016.05.016 – volume: 106 start-page: 1631 year: 2009 ident: 959_CR17 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.91067.2008 – volume: 592 start-page: 4775 year: 2014 ident: 959_CR27 publication-title: J Physiol doi: 10.1113/jphysiol.2014.278358 – volume-title: An Aging World: 2015 year: 2016 ident: 959_CR1 – volume: 96 start-page: 1385 year: 2004 ident: 959_CR13 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.01081.2003 – volume: 21 start-page: 1703 year: 2003 ident: 959_CR21 publication-title: J Hypertens doi: 10.1097/00004872-200309000-00020 – volume: 49 start-page: 208 year: 2017 ident: 959_CR24 publication-title: Horm Metab Res doi: 10.1055/s-0042-124189 – volume: 25 start-page: 729 year: 2002 ident: 959_CR14 publication-title: Muscle Nerve doi: 10.1002/mus.10092 – volume: 54 start-page: 206 year: 2016 ident: 959_CR26 publication-title: Endocrine doi: 10.1007/s12020-016-1049-8 – volume: 86 start-page: 10 year: 2017 ident: 959_CR25 publication-title: Clin Endocrinol doi: 10.1111/cen.13145 – volume: 279 start-page: E663 year: 2000 ident: 959_CR10 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.2000.279.3.E663 – volume: 46 start-page: 85 year: 2009 ident: 959_CR22 publication-title: Acta Diabetol doi: 10.1007/s00592-009-0112-9 – volume: 8 start-page: 457 year: 2012 ident: 959_CR30 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2012.49 |
| SSID | ssj0017571 |
| Score | 2.2877107 |
| Snippet | The effects of catecholamine excess due to pheochromocytoma on body composition, including skeletal muscle mass, are unknown. Here, we investigated the effects... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 694 |
| SubjectTerms | Adrenal Gland Neoplasms - pathology Adrenal Gland Neoplasms - urine Body composition Body fat Catecholamines Female Humans Linear Models Male Medicine Medicine & Public Health Metabolic Diseases Metabolites Metanephrine - urine Middle Aged Muscle, Skeletal - pathology Musculoskeletal system Normetanephrine - urine Odds Ratio Organ Size Original Article Orthopedics Pheochromocytoma Pheochromocytoma - pathology Pheochromocytoma - urine Sarcopenia Skeletal muscle |
| SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9tAEB7RRKp6gdJCG0jRIvUEMrKzD3tvoAoageCUSHCy9hWB0thR7Rzor--sX4inxNnj9Xp257Xf7AzAT6p4ktBQBcoJFTCaiECNYh6EieUj6-upV53nLq_EeMrOr_l1c4-7aLPdW0iy0tTdZTdfecZnTHi4nsuAfoA-jxKZ9KB_8vvm4rQDD2JexVloCRkKeyxbMPOlQR6bo2c-5jN8tDI7ZxswaSdcZ5vMj1alPjL_ntRyfOcffYb1xg0lJ_W-2YQ1l32Bj5cN0P4VjutbBySfkWKOlglddLJYFUhLFuhuk7uMNBVZC-KPcsny1uXm1uf2mfsyX6gtmJ6dTn6Ng6bZQmCoFGUQa2VDZ7jVVmPQpVD20XxyaaLQOSG5nqmRiZxkBjUiqgU1M1xbIy23KvLNyrahl-WZ-w6EhVSzeBZboQRLRlIprplDOyiNFZFwAwhbnqemqUTuG2L8SbsayhVnUuRM6jmT0gEcdK8s6zIcbxEP24VMG4ksUh_oRlGMKmwA-91jlCUPkKjM5auKBsNDymIc4lu9Abqv-eZKCaPhAA7bxXwY_NWp7LyLehc-oT8m62zgIfTKvyv3A32eUu81e_w_UYD1bQ priority: 102 providerName: Springer Nature |
| Title | Change of skeletal muscle mass in patients with pheochromocytoma |
| URI | https://link.springer.com/article/10.1007/s00774-018-0959-3 https://www.ncbi.nlm.nih.gov/pubmed/30238430 https://www.proquest.com/docview/2110117318 https://www.proquest.com/docview/2111143473 |
| Volume | 37 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFH_aVglxmWDjozAqT-I0ZJHEX_EJCuqYhjZNE5XKKXJsV0PQpCPtgf-e58TJhCZ2TRzHet_Pz34_gLfMiDxniaHGS0M5yyU1mRI0yZ3IXOin3iLPXVzKszk_X4hF3HBr4rHK3ia2htrVNuyRvw-JSpoqFMEP61saUKNCdTVCaOzCCE1wjnI--jS7vLoe6ghKtCkXOkWOeq90X9dM2jaiGPpgKh3K_0JT9q9nuhdu3iuVth7o9Ansx9CRTDteP4UdXx3Ao4tYHD-Ej91NAVIvSfMTvQmG1WS1bXAsWWGITH5UJHZRbUjYfiXrG1_bm3Aez_7Z1CvzDOans2-fz2gESKCWabmhqjQu8Va40pWYKBnUV3R5Qts08V5qUS5NZlOvuUUrhqpsllaUzmonnEkDwNhz2Kvqyr8EwhNWcrVUThrJ80wbI0ru0Xdp62Qq_RiSnjiFjd3DA4jFr2Loe9zSs0B6FoGeBRvDyfDJumud8dDgo57iRdSiprjj-RiOh9co_6GoYSpfb9sxmNIxrnCKFx2nhr8FQKScs2QM73rW3U3-36W8engpr-ExBk26O7J7BHub31v_BgOTTTmBXbVQExhNv3z_OptEWcSn82z6F2h64Jw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7BIkEvVR_QboHWSOUCsprEj8SHqvQBWh67qhBI3IJje0XVbrIlu6r4U_2NHeeFKgQ3znFsa_zZM-MZzwfwnmmRJCzQVDupKWeJpDqKBQ0SKyLr66lXzHPDkRyc86MLcbEAf9u3MD6tsj0Tq4PaFsbfkX_wjkoYxgjBT9Pf1LNG-ehqS6FRw-LY3fxBl638ePgN13c7ig72z74OaMMqQA1TckbjTNvAGWEzm6F3oRHkqCeEMmHgnFQiG-vIhE5xg1sf8a_HRmTWKCusDj0rF_a7CEvcv2jtwdKX_dH30y5uEYvKxUMlzPGciVUbRw2qsqVoaqHr7tMNhKLsf014x7y9E5qtNN7BM3jamKrkc42t57Dg8hewPGyC8S9hr36ZQIoxKX-i9kIznkzmJbYlEzTJyY-cNFVbS-Kve8n0yhXmyuf_mZtZMdGrcP4ooluDXl7k7jUQHrCMx-PYSi15EimtRcYd6kplrAyl60PQCic1TbVyT5rxK-3qLFfyTFGeqZdnyvqw0_0yrUt1PNR4o5V42uzaMr3FWB-2us-433wQReeumFdt0IVkPMYuXtUr1Y3mCZgSzoI-7LZLd9v5vVN58_BU3sHK4Gx4kp4cjo7X4QkabKpOF96A3ux67jbRKJplbxskErh8bPD_AwipHXw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQZTnQgtGggvIahK_4gPi1a5aSlcVolJvwbEdFbWbLM2uqv41fh3jvCpU0VvPcRxr_Hnmm8x4BuA1MyJNWWSo8dJQzlJJTaIEjVInEhfqqTed5w6mcveIfz0Wxyvwp78LE9Iqe53YKGpX2fCPfCs4KnGsEIJbRZcWcbg9-TD_TUMHqRBp7dtptBDZ95cX6L7V7_e2ca_fJMlk58eXXdp1GKCWabmgKjcu8la43OXoaRgEPNoMoW0ceS-1yAuT2NhrblEN4FkwhRW5s9oJZ-LQoQvnvQOrCq0iH8Hq553p4fchhqFE4-6hQeaoc5TuY6pRU8IUaRe68SH1QGjK_rWK16jutTBtY_0m9-FeR1vJpxZn67DiywewdtAF5h_Cx_aWAqkKUp-iJUNKT2bLGseSGdJz8qskXQXXmoRfv2R-4it7EnIB7eWimplHcHQronsMo7Iq_VMgPGI5V4Vy0kieJtoYkXOPdlNbJ2PpxxD1wslsV7k8NNA4y4aay408M5RnFuSZsTG8HV6Zt2U7bhq80Us8605wnV3hbQyvhsd49kJAxZS-WjZj0J1kXOEUT9qdGr4WmjGlnEVjeNdv3dXk_13Ks5uX8hLWEPTZt73p_nO4i9xNt5nDGzBanC_9JvKjRf6iAyKBn7eN_b8ciiGo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Change+of+skeletal+muscle+mass+in+patients+with+pheochromocytoma&rft.jtitle=Journal+of+bone+and+mineral+metabolism&rft.au=Lee%2C+Seung+Hun&rft.au=Kwak%2C+Mi+Kyung&rft.au=Ahn%2C+Seong+Hee&rft.au=Kim%2C+Hyeonmok&rft.date=2019-07-01&rft.pub=Springer+Nature+B.V&rft.issn=0914-8779&rft.eissn=1435-5604&rft.volume=37&rft.issue=4&rft.spage=694&rft.epage=702&rft_id=info:doi/10.1007%2Fs00774-018-0959-3&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8779&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8779&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8779&client=summon |